Reishi Side Effects

Reported Reishi side effects

Reishi has an excellent overall safety profile, consistent with its status as a food-grade mushroom consumed for millennia in East Asia. Most reported side effects are mild and transient, though several serious considerations warrant attention. Common side effects (5-15% of users): Mild gastrointestinal upset — nausea, loose stools, abdominal discomfort, particularly in the first 1-2 weeks of use or at higher doses. Often resolves with continued use or dose reduction Dry mouth and nosebleeds — related to the classical "drying" properties described in traditional Chinese medicine Dizziness in a minority, usually mild and transient Headache in some users Uncommon side effects (<5%): Allergic reactions — skin rash, itching; more common in individuals with mushroom allergies Mild increases in liver enzymes — generally reversible on discontinuation Itchy skin or skin rashes Mild immunosuppression at very high doses (paradoxical effect) Increased bruising or bleeding — related to antiplatelet activity of triterpenoids Rare but serious: Hepatotoxicity — two case reports (Wanmuang et al. 2007; Yuen and Gohel 2005) describe fatal fulminant hepatitis associated with reishi powder consumption. Both cases involved high-dose, prolonged consumption of unextracted fruiting body powder. This underscores the importance of using properly extracted preparations (dual extraction or standardized extracts) rather than raw powder, and avoiding excessive doses Bleeding complications — case reports of post-surgical bleeding and cases of epistaxis associated with high-dose reishi and anticoagulant use Anaphylactic reactions — rare but documented in individuals with severe mushroom allergies Autoimmune activation — theoretical concern given immunomodulatory properties Drug interactions: Anticoagulants (warfarin, DOACs) and antiplatelet agents (aspirin, clopidogrel) — additive bleeding risk due to reishi's antiplatelet triterpenoids and adenosine content; monitor for bruising and bleeding, consider discontinuing reishi 1-2 weeks before surgery Immunosuppressants (cyclosporine, tacrolimus, mycophenolate, azathioprine, biologics) — reishi's immune-activating properties may theoretically counteract immunosuppression; avoid in transplant recipients and active autoimmune disease Diabetes medications — additive glucose-lowering effect; monitor blood glucose in diabetics on medication Antihypertensive medications — mild additive blood pressure lowering possible; monitor blood pressure CYP450 substrates — reishi may inhibit CYP2E1 and CYP3A4 at high doses, potentially affecting medications metabolized by these enzymes; clinical significance varies Quality issues affecting safety: Unextracted reishi powder — poorly absorbed, less effective, and possibly more problematic for liver than properly extracted preparations; avoid large doses of simple dried fruiting body powder Mycelium-on-grain products — often contain predominantly grain starch with minimal active compound, but also may contain aflatoxins or other mold contaminants if improperly processed Heavy metal contamination — less of an issue than with wild Asian ginseng, but all commercial mushroom products should have third-party testing for heavy metals, pesticides, and microbial contamination Pregnancy and lactation: No established safety data in pregnancy or breastfeeding Traditionally used in small doses in Chinese medicine during pregnancy for certain indications, but data are insufficient for modern evidence-based recommendation Generally best avoided during pregnancy and breastfeeding Preoperative considerations: Discontinue reishi 1-2 weeks before scheduled surgery due to antiplatelet effects Inform anesthesiologists and surgeons of any reishi supplementation

When to continue, reduce, or stop Reishi

Reishi contraindications

Reishi has a favorable safety profile overall but has specific populations who should avoid it or use only under medical supervision. Absolute contraindications: Known reishi or mushroom allergy — risk of severe reactions including anaphylaxis (rare) Active bleeding or hemophilia — reishi's antiplatelet effects increase bleeding risk Organ transplant recipients on immunosuppression — reishi immunoactivation may theoretically counteract immunosuppression and trigger rejection Active autoimmune disease flare — immune activation may worsen flares (though in remission, reishi's immunomodulatory effects could theoretically balance) Pregnancy and breastfeeding — insufficient safety data; traditional use varies but modern evidence-based recommendation is avoidance Relative contraindications (caution with medical supervision): Anticoagulation therapy at therapeutic INR — reishi antiplatelet effects may add to bleeding risk; monitor INR, bruising, and bleeding signs Antiplatelet therapy (aspirin, clopidogrel) — additive bleeding risk Scheduled surgery within 2 weeks — discontinue before elective procedures Liver disease — use only dual-extracted preparations at moderate doses; avoid high-dose unextracted powder; monitor liver enzymes Stable autoimmune disease in remission — possible benefit from immunomodulation, but caution warranted; monitor symptoms Hypotension — mild additive blood pressure lowering Active GI bleeding or ulcer disease — may worsen bleeding risk Drug interactions (summary): Anticoagulants and antiplatelet agents — additive bleeding risk Immunosuppressants (cyclosporine, tacrolimus, azathioprine, mycophenolate, biologics) — may counteract immunosuppression Diabetes medications — additive glucose-lowering effects Antihypertensives — additive blood pressure lowering CYP450 substrates (high-dose reishi may modestly inhibit CYP2E1 and CYP3A4) — relevant for medications metabolized by these enzymes Chemotherapy — some chemotherapy protocols exclude or monitor for interactions with immunomodulating supplements; discuss with oncologist Product quality issues affecting contraindication-type decisions: Unextracted reishi powder in high doses — increased hepatotoxicity risk (two case reports of fatal liver failure); avoid large doses of raw powder Mycelium-on-grain products — often predominantly starch with minimal active compound; may contain aflatoxins if improperly processed Wild-harvested reishi from uncertain sources — potential contamination with heavy metals, pesticides Red flags during supplementation requiring discontinuation: Unexplained bruising, prolonged bleeding from minor cuts, or bleeding gums Jaundice, dark urine, right upper quadrant pain, or other signs of hepatic dysfunction Rash, hives, swelling, or difficulty breathing (allergic reaction) Symptoms of low blood sugar in diabetics Flare of known autoimmune condition New-onset rash or severe itching Fever, chills, or severe GI symptoms Pediatric use: Limited safety data in children Traditional use exists in Chinese medicine but at reduced doses (25-50% of adult dose) Avoid in children under 18 without specialist guidance Particularly avoid in children with autoimmune disorders or on immunosuppression Geriatric use: Generally well tolerated in older adults May be particularly beneficial for immune function and sleep support Monitor for interactions with polypharmacy common in older adults Consider slightly lower starting doses (500mg-1g/day) due to possible age-related pharmacokinetic changes

Why vendor quality drives Reishi side-effect frequency

Research-compound communities consistently report that adverse-event frequency tracks with source quality. Three reasons: (1) impurity profiles vary by lab (residual synthesis byproducts can trigger reactions); (2) mislabeled mass means actual dose can be 50-150% of stated dose; (3) reconstitution-grade water and capping methodology affect long-term storage stability. COA-verified vendors with published HPLC data minimize all three failure modes. Check a vendor's COA record and Trust Score before you buy.

Reishi side effects FAQ

Research-use disclaimer. All safety information on this page summarizes published research literature and community-reported reactions. It is not medical advice and not authorization for human consumption. Always consult a licensed practitioner before any compound enters a clinical context. Compounds linked from this page are sold for research-use only.
Affiliate disclosure. See our affiliate disclosure .